1. Home
  2. BCRX vs IDT Comparison

BCRX vs IDT Comparison

Compare BCRX & IDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCRX
  • IDT
  • Stock Information
  • Founded
  • BCRX 1986
  • IDT 1990
  • Country
  • BCRX United States
  • IDT United States
  • Employees
  • BCRX N/A
  • IDT N/A
  • Industry
  • BCRX Biotechnology: Biological Products (No Diagnostic Substances)
  • IDT Telecommunications Equipment
  • Sector
  • BCRX Health Care
  • IDT Telecommunications
  • Exchange
  • BCRX Nasdaq
  • IDT Nasdaq
  • Market Cap
  • BCRX 1.4B
  • IDT 1.3B
  • IPO Year
  • BCRX 1994
  • IDT 1996
  • Fundamental
  • Price
  • BCRX $7.12
  • IDT $50.21
  • Analyst Decision
  • BCRX Strong Buy
  • IDT
  • Analyst Count
  • BCRX 11
  • IDT 0
  • Target Price
  • BCRX $19.00
  • IDT N/A
  • AVG Volume (30 Days)
  • BCRX 4.8M
  • IDT 137.5K
  • Earning Date
  • BCRX 11-03-2025
  • IDT 12-04-2025
  • Dividend Yield
  • BCRX N/A
  • IDT 0.48%
  • EPS Growth
  • BCRX N/A
  • IDT 18.50
  • EPS
  • BCRX N/A
  • IDT 3.01
  • Revenue
  • BCRX $599,816,000.00
  • IDT $1,231,495,000.00
  • Revenue This Year
  • BCRX $41.57
  • IDT $0.77
  • Revenue Next Year
  • BCRX $6.25
  • IDT N/A
  • P/E Ratio
  • BCRX N/A
  • IDT $16.67
  • Revenue Growth
  • BCRX 45.38
  • IDT 2.13
  • 52 Week Low
  • BCRX $6.00
  • IDT $44.77
  • 52 Week High
  • BCRX $11.31
  • IDT $71.12
  • Technical
  • Relative Strength Index (RSI)
  • BCRX 51.36
  • IDT 47.07
  • Support Level
  • BCRX $6.71
  • IDT $47.90
  • Resistance Level
  • BCRX $7.17
  • IDT $52.45
  • Average True Range (ATR)
  • BCRX 0.26
  • IDT 1.23
  • MACD
  • BCRX 0.01
  • IDT 0.04
  • Stochastic Oscillator
  • BCRX 67.42
  • IDT 48.54

About BCRX BioCryst Pharmaceuticals Inc.

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.

About IDT IDT Corporation Class B

IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.

Share on Social Networks: